0 followers
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical developme... Read more
Robert Jacks
Bristol-Myers Squibb
163 followers
Viatris
30 followers
Omnicell
20 followers
Syneos Health
16 followers
NYU Langone Health
12 followers
Karyopharm Therapeutics
12 followers
DispatchHealth
6 followers
Apellis Pharmaceuticals
6 followers
Codexis
4 followers
Charlie Health
4 followers
AbbVie
149 followers
Discover companies